Top 30 Medical Startup Investors in New Zealand (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Icehouse Ventures
VC Fund
|
4 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $612k–$16M |
|
IP Group
VC Fund
|
3 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$23M |
|
Enterprise Angels
VC Fund
|
3 | New Zealand, United States, United Kingdom | Seed, Angel | Software, Information Technology, Health Care | $153k–$4.3M |
|
Pacific Channel
VC Fund
|
2 | New Zealand, Australia, Canada | Seed, Venture - Series Unknown, Series A | Manufacturing, Medical Device, Health Care | $938k–$15M |
|
Global from Day One
VC Fund
|
2 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Medical Device | $612k–$18M |
|
K1W1
VC Fund
|
2 | New Zealand, United States | Seed, Series A | Software, Artificial Intelligence, SaaS | $419k–$18M |
|
Uniservices
VC Fund
|
2 | New Zealand, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Medical Device, Manufacturing | $1M–$4M |
|
Flying Kiwi Angels
VC Fund
|
2 | New Zealand, United States | Seed, Angel, Pre-Seed | Software, Medical Device, Information Technology | $334k–$4.3M |
|
Matū Group
VC Fund
|
2 | New Zealand, United States | Seed, Pre-Seed, Venture - Series Unknown | Biotechnology, Health Care, Robotics | |
|
Movac
VC Fund
|
2 | New Zealand, United States, Australia | Seed, Series A | Software, SaaS, E-Commerce | $795k–$18M |
|
Bioshore Ventures
VC Fund
|
1 | New Zealand | Seed | Medical, Health Care, Medical Device | |
|
New Zealand Venture Investment Fund
VC Fund
|
1 | New Zealand, United States, Japan | Seed, Series A, Angel | Software, Biotechnology, SaaS | $400k–$8.8M |
|
Hillfarrance Venture Capital
VC Fund
|
1 | New Zealand, United Kingdom | Seed, Pre-Seed | Software, Animation, Information Technology | $473k–$2M |
|
AngelHQ
VC Fund
|
1 | New Zealand, United States, Canada | Seed, Angel, Series A | Software, Apps, Health Care | $350k–$3M |
|
Novaquest Capital Management
VC Fund
|
1 | United States, New Zealand, United Kingdom | Private Equity, Series A, Post-IPO Equity | Biotechnology, Health Care, Pharmaceutical | $3.6M–$210M |
|
Sante Ventures
VC Fund
|
1 | United States, Canada, Japan | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.9M–$80M |
|
Hostplus
VC Fund
|
1 | Australia, United Kingdom, United States | Series A, Series B, Series C | Software, Biotechnology, Semiconductor | $6.3M–$111M |
|
GD1 (Global From Day One)
VC Fund
|
1 | New Zealand, United States, China | Seed, Series A, Pre-Seed | Software, Information Technology, SaaS | $600k–$16M |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
KP Rx
VC Fund
|
1 | New Zealand | Seed | Medical, Health Care, Medical Device | |
|
IP Group Australia
VC Fund
|
1 | Australia, New Zealand | Seed, Series A, Pre-Seed | Biotechnology, Manufacturing, Renewable Energy | $811k–$29M |
|
Olympus Innovation Ventures
VC Fund
|
1 | Spain | Series B | Medical, Biopharma, Biotechnology | |
|
American Gastroenterological Association
VC Fund
|
1 | United States | Series C | Mobile, Medical, Health Care | |
|
Alt Ventures
VC Fund
|
1 | New Zealand | Seed, Convertible Note | Software, Linux, Security | $1M–$6.4M |
|
Callaghan Innovation
VC Fund
|
1 | New Zealand, United States, Australia | Grant, Pre-Seed, Seed | Manufacturing, Software, Information Technology | $5.9k–$1M |
|
New Zealand Growth Capital Partners
VC Fund
|
1 | New Zealand, United States, Australia | Seed, Venture - Series Unknown, Series A | Software, Medical Device, Manufacturing | $608k–$17M |
|
Cure Kids Ventures
VC Fund
|
1 | New Zealand | Seed, Pre-Seed, Series A | Medical Device, Health Care, Manufacturing | $1.7M–$4.3M |
|
Auckland UniServices
VC Fund
|
1 | New Zealand | Seed, Pre-Seed | Medical, Marketing, Nutrition | |
|
ArcAngels
VC Fund
|
1 | New Zealand | Series A | Medical, Genetics, Health Care | |
|
Olympus Corporation of the Americas
VC Fund
|
1 | United States, New Zealand | Grant, Series A, Series C | Medical, Biotechnology, Health Care | |
| Access all 36 investors in New Zealand Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 213
- Round size: Seed $612k–$5M; Series A $2.2M–$16M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Vessev is a maritime trasportantion company that offers hydrofoiling electric vessels for travelling through water.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 193
- Round size: Seed $393k–$7.6M; Series A $2M–$23M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Barocal — Barocal is a Zero-carbon refrigeration pioneer.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Kynos Therapeutics — Leading an inflammation revolution
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Angel
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 120
- Round size: Seed $153k–$4.3M; Angel $229k–$651k
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $12M in 2019
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Manufacturing, Medical Device, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, Australia, Canada
Investor stats
- Total investments: 45
- Round size: Seed $938k–$5M; Series A $6M–$15M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Tectonus — Revolutionary self-centring seismic connections that protect structures in earthquake sequences.
- Regen —
- Androgenix —
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Medical Device
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 29
- Round size: Seed $612k–$5M; Series A $1.2M–$18M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 100
- Round size: Seed $550k–$4.1M; Series A $419k–$18M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Evnex — NZ manufactured and installed EV chargers for homes and businesses. Starting at $2,295 inc for a charger and full install - Electric vehicle charging simplified.
- Groov —
- Astrix Astronautics — Inflatable, rigidising deployment enables low-cost spacecraft solar arrays, high gain antennas, powering earth with solar energy from space, and more.
Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Health Care, Medical Device, Manufacturing
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 19
- Round size: Seed $1M–$2.8M; Venture - Series Unknown $3.2M–$4M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- RosterLab — RosterLab goal is to automate every part of the rostering process for healthcare.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Flying Kiwi Angels ? Helping Kiwi Startups
Show more...Investment focus
- Industry: Software, Medical Device, Information Technology
- Stage:Seed, Angel, Pre-Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 21
- Round size: Seed $334k–$4.3M; Angel $592k–$918k; Pre-Seed $473k–$1.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- PAM NZ —
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Robotics
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 13
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Liquium —
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Ampersand Technologies —
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 61
- Round size: Seed $1.5M–$4.4M; Series A $795k–$18M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $125M in 2022
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- LawVu — Our all-in-one connected platform enables your legal team to manage all legal matters, contracts, spend and legal operations. Book your free demo now.
- 1Above — 1Above is designed with Vitamins, Electrolytes and Super Antioxidant to help you recover faster on Travel, Work, Party occasions. Well known to help combat jet lag since 2010.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bioshore Ventures is an Australian venture capital firm focused on early-stage medical technology and biotech investments. The firm addresses a funding gap in Australia's strong medtech R&D ecosystem by providing specialized risk capital to commercialize innovative healthcare technologies.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
New Zealand Venture Investment Fund, a New Zealand-based private equity fund, manages fund of funds investments and direct co-investments.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series A, Angel
- Geography: New Zealand, United States, Japan
Investor stats
- Total investments: 36
- Round size: Seed $428k–$1.2M; Angel $400k–$4.3M; Series A $1.4M–$8.8M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- MAPTO — Bringing industries together since 2008, Mapto.com stands as the premier platform for a global business directory. Serving millions of companies and suppliers worldwide.Mapto, the “Business Development Guide,” has been specially designed to offer an e-commerce solution that brings together all companies in the world and provides an excellent B2Cuser experience without sacrificing B2B functionality. The most significant difference from other marketplaces is that it is customer-supported!In today’s world, product, manufacturer, and communication demands are the basis of e-commerce searches on the internet. It restructures the “roadmap of e-commerce” by bringing all these demands together and making them accessible to users.
- Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
- Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
We exist to serve great entrepreneurs with honest advice and education, investment capital that is fair, and an open door to our international network and connections.
Show more...Investment focus
- Industry: Software, Animation, Information Technology
- Stage:Seed, Pre-Seed
- Geography: New Zealand, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $606k–$2M; Pre-Seed $473k–$1.2M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Scannable — Scannable helps Arborists, Rope Access Technicians, Riggers, and Rescuers easily manage PPE and safety equipment.
- Space Rock Games — Space Rock Games is the developer behind Criminals Within - a cooperative-only action game set in a medieval fantasy kingdom. Sign up to receive exclusive development updates!
- Floating Rock Studio — Floating Rock Studio
Learn about Angel HQ, Wellington's Angel Investing Network - the meeting place for ambitious startups and passionate investors.
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Angel, Series A
- Geography: New Zealand, United States, Canada
Investor stats
- Total investments: 22
- Round size: Seed $350k–$3M; Angel $367k–$1M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- chnnl — Optimise your employee wellbeing strategy with chnnl. Centralised resource management, track psychosocial risks and team psychological wellbeing measurement.
- Upstock — Manage wholesale orders with a simple app.
- Factor — Plug and play forecasting and pricing tools for modern energy utilities.
About NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and gro...
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Private Equity, Series A, Post-IPO Equity
- Geography: United States, New Zealand, United Kingdom
Investor stats
- Total investments: 29
- Round size: Series A $3.6M–$210M; Private Equity $5.3M–$200M; Post-IPO Equity $50M–$125M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $275M in 2019
Portfolio highlights
- Mirna — Soon to be launched, our AI-powered MI:RNA platform is designed to detect a range of diseases prior to the development of clinical signs. This groundbreaking
- Mileutis — At Mileutis, we focus on discovery, development and commercialization of novel and biologically sourced, safe and residue free therapies for animal health.
- Gallant — Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.The company offers services that include retrieving valuable stem and regenerative cells, enabling pet owners to preserve their pet's young stem, and use them in treatment when necessary.Gallant Pet was established in 2018 by Aaron Hirschhorn andis headquartered in San Diego, California.
Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Japan
Investor stats
- Total investments: 118
- Round size: Series A $1.9M–$32M; Series B $2.6M–$61M; Series C $5M–$80M
- Lead/follow: 62% lead, 38% follow
- Last fund: Likely still investing — raised $260M in 2021
Portfolio highlights
- REVELOHEALTH — REVELOHEALTH provides advisory services. Their services include healthcare provider solutions, revenue cycle solutions, price transparency solutions, payment integrity, network claim repricing, data analytics, denial management, and direct-to-employer.
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
- SONIRE Therapeutics — SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd..
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more...Investment focus
- Industry: Software, Biotechnology, Semiconductor
- Stage:Series A, Series B, Series C
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 62
- Round size: Series A $6.3M–$49M; Series B $20M–$111M; Series C $13M–$60M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Gradiant — Gradiant deploys advanced water treatment solutions and technologies to solve the toughest water challenges for the world's critical industries.
- First Light Fusion — First Light Fusion was spun out from the University of Oxford and focuses on researching energy generation by inertial confinement fusion. Its platform explores a number of alternative research directions that harness fundamental physics focusing on power generation and theoretical analysis, detailed numerical simulation, and experimentalvalidation that helps clients to discover a new source of energy. The company directly employs a team of engineers and physicists and collaborates closely with a number of academic organizations, including the University of Oxford, Warwick University, UCL, and Imperial College, London.The company was founded by Professor Yiannis Ventikos and Dr. Nicholas Hawker and is based in Yarnton, Oxfordshire.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 58
- Round size: Seed $600k–$7.3M; Pre-Seed $860k–$2.3M; Series A $1.8M–$16M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Vessev — Vessev is a maritime trasportantion company that offers hydrofoiling electric vessels for travelling through water.
- VXT — Automate, integrate, and accelerate. Get more from your phone calls for less. VXT Call is a simple, mobile and powerful system.
- Caruso — AI-native fund administration for private markets. Trusted by 900+ real estate, private credit, and private equity funds to save time, impress investors, and grow AUM.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 217
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
KP Rx is a 100% founder-owned investment firm focusing on private and early-stage public healthcare investments in Australia and New Zealand.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ip Group Australia build and support outstanding intellectual property-based companies.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Renewable Energy
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$2.3M; Pre-Seed $811k–$896k; Series A $3M–$29M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
- Additive Assurance — Additive Assurance offers quality assurance for metal additive manufacturing.
- Jetra Therapeutics — Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Olympus Innovation Ventures is an investment firm.
Show more...Investment focus
- Industry: Medical, Biopharma, Biotechnology
- Stage:Series B
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Universal Diagnostics — Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early.The UDX diagnosticplatform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis.UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I).To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA, a 501(c6) organization, administers all membership and publicpolicy activities, while the AGA Institute, a 501(c3) organization, runs the organization’s practice, research and educational programs.On a monthly basis, the AGA Institute publishes two highly respected journals, Gastroenterology and Clinical Gastroenterology and Hepatology.The organization's annual meeting is Digestive Disease Week®, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.The AGA Research Foundation provides digestive disease research grants on behalf of the AGA Institute.
Show more...Investment focus
- Industry: Mobile, Medical, Health Care
- Stage:Series C
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Oshi Health — Oshi Health is a virtual-first gastroenterology (GI) clinic that diagnoses, treats and remotely monitors digestive (GI) conditions. Patients work with Oshi Health's integrated care team of gastroenterologists and GI-specialized nurse practitioners, registered dietitians, behavioral psychologists and health coaches to determine the root causesof their symptoms and use a personalized care plan that includes medication, dietary interventions and stress/anxiety reduction to get symptoms under control. This yields improved health outcomes, quality of life, satisfaction with care and workplace productivity while reducing overall healthcare cost.
AmpliPHI Ventures provides wholesale investors access to the private market investment opportunities.
Show more...Investment focus
- Industry: Software, Linux, Security
- Stage:Seed, Convertible Note
- Geography: New Zealand
Investor stats
- Total investments: 6
- Round size: Seed $1M–$6.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Arcanum AI — Rapidly build and integrate machine learning features with the Accelerate Platform library of pre-built workflows. Hosted API or deploy into your own cloud.
- Goodair Nosebuds — Goodair Nosebuds develops mechanical breathing technology to restore natural nasal functioning. It specializes in gently massaging upper airways using air, stimulating the body's natural defense system, and improving airway clarity, enabling users to enhance their well-being by balancing airway hydration.
- Sandfly Security — Sandfly is an agentless Linux EDR and incident response platform. Sandfly finds Linux threats without endpoint agents.
Callaghan Innovation is a stand-alone Crown Entity established on 1 February, 2013. Their role hasn’t previously existed in New Zealand.When they succeed, all New Zealanders will benefit from a stronger economy, higher value exports, more productive and sustainable resource use, more jobs and higher incomes.International evidence showsadvanced technology institutes like Callaghan Innovation have been successful at helping businesses build innovation capability that contributes to their growth and the broader economy.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Grant, Pre-Seed, Seed
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 922
- Round size: Seed $593k–$1M; Grant $5.9k–$39k; Pre-Seed $607k–$716k
- Lead/follow: 98% lead, 2% follow
Portfolio highlights
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Wallo Pay — Wallo Pay, incorporated in July 2023, is a New Zealand-based fintech startup transforming digital payments for consumers and businesses. Operating across Aotearoa and with plans to expand into Australia, our founder-led team is building a B2C and B2B payments platform powered by banking APIs, enabling direct, real-time account-to-accounttransactions. By bypassing traditional card networks, Wallo Pay slashes merchant service fees from 1.5–2.5% to 0.6% or less, potentially saving New Zealand businesses $700M annually. Our product suite includes a Consumer Mobile App with QR-based and unique digital ID based payments, a Business Mobile App, and a Business Web Portal, targeting retail, hospitality, and other businesses accepting payments from end customers.Aligned with New Zealand’s Consumer Data Right (2025), Wallo Pay’s open API infrastructure empowers developers, fintech startups, and public agencies to build innovative solutions, from loyalty programs to interoperable transport payments. Our platform fosters an inclusive ecosystem, enabling business of all sizes and innovators to participate in the digital economy with low-cost, scalable payment tools. Since starting MVP development in June 2024, Wallo Pay is gearing up for an alpha pilot in Q3–Q4 2025, driving transparency, affordability, and trust in Aotearoa’s payment landscape.
- Forever Harvest — Forever Harvest is a food technology startup specializing in cellular horticulture.
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, Medical Device, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 48
- Round size: Seed $830k–$4.9M; Series A $6.2M–$17M; Venture - Series Unknown $608k–$6.1M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more...Investment focus
- Industry: Medical Device, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 9
- Round size: Seed $1.7M–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- chnnl — Optimise your employee wellbeing strategy with chnnl. Centralised resource management, track psychosocial risks and team psychological wellbeing measurement.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- ISpy Nits — ISpy Nits manufacturer develops a biofluorescent powder for treating lice and nits. The company's product kit includes lotion and a non-toxic glow powder that binds to the egg sheath to intensify the effect. As the chemicals interact with bioluminescent proteins, they emit light that is visible to the human eye, identifying lice and their eggsand removing them.
UniServices grows and commercialises the research and expertise of the University of Auckland to create real-world impact.
Show more...Investment focus
- Industry: Medical, Marketing, Nutrition
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Opo Bio — Opo Bio develops cell lines for the cultivated meat industry and researchers.They are building a multi-species and multi-cell type product bank for research and commercial usage. They are creating infrastructure that will enable the industry to progress and more effectively scale.
- PhaseFoam — PhaseFoam creates innovative thermal management solutions that harness natural energy in an intelligent manner to mitigate heat. As demonstrated in extensive trials, PhaseFoam's technology offers substantial value and benefits while requiring low maintenance and overhead.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
At ArcAngels Funding, we connect female entrepreneurs across New Zealand to venture capital and investment to help their businesses grow.
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Engender Technologies — Engender has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells, enabling dairy farmers to accelerate genetic gain and improve productivity. Engender has secured scientific and laboratory facilities from one of the world’s largest AI companies in exchange for an option for it to non-exclusively licenseEngender’s technology.
At Olympus, we put a lot of good back into the world, and what we do, really matters.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Grant, Series A, Series C
- Geography: United States, New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Swan EndoSurgical — Swan EndoSurgical provides endoluminal surgical robotic systems that will enhance patient care everywhere.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
Medical Investor funding in New Zealand at a glance
Stats across 61 deals from 36 investors.
Access all 36 investors in New Zealand Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in New Zealand investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 36 investors investing in New Zealand Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!